EE200300587A - Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine - Google Patents

Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine

Info

Publication number: EE200300587A
Authority: EE; Estonia
Prior art keywords: preparation; pharmaceutical composition; liquid pharmaceutical; liquid; composition
Prior art date: 2001-05-25

Application number

EEP200300587A

Other languages

English (en)

Estonian (et)

Inventor

Mahesh Kulkarni Neema

Schneider Michael

Bernard Silbering Steven

Richard Meyer-Wonnay Hans

Sanii-Yahyai Nahid

Original Assignee

Warner-Lambert Company Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-25

Filing date

2002-04-29

Publication date

2004-02-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26968180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200300587(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-04-29 Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc

2004-02-16 Publication of EE200300587A publication Critical patent/EE200300587A/xx

Links

239000007788 liquid Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Anesthesiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Pyrrole Compounds (AREA)

EEP200300587A 2001-05-25 2002-04-29 Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine EE200300587A (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US29383201P	2001-05-25	2001-05-25
US34373301P	2001-10-25	2001-10-25
PCT/IB2002/001500 WO2002094220A1 (en)	2001-05-25	2002-04-29	Liquid pharmaceutical composition

Publications (1)

Publication Number	Publication Date
EE200300587A true EE200300587A (et)	2004-02-16

Family

ID=26968180

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300587A EE200300587A (et)	2001-05-25	2002-04-29	Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine

Country Status (43)

Country	Link
US (2)	US20020198261A1 (de)
EP (1)	EP1395242B1 (de)
JP (1)	JP2004534764A (de)
KR (1)	KR100582963B1 (de)
CN (1)	CN100346779C (de)
AP (1)	AP1815A (de)
AR (1)	AR033922A1 (de)
AT (1)	ATE334656T1 (de)
AU (1)	AU2002258026B2 (de)
BG (1)	BG108376A (de)
BR (1)	BR0209973A (de)
CA (1)	CA2446574C (de)
CR (1)	CR7150A (de)
CY (1)	CY1105147T1 (de)
CZ (1)	CZ299755B6 (de)
DE (1)	DE60213592T2 (de)
DK (1)	DK1395242T3 (de)
DO (1)	DOP2002000403A (de)
EA (1)	EA008087B1 (de)
EE (1)	EE200300587A (de)
EG (1)	EG24078A (de)
ES (1)	ES2265040T3 (de)
GE (1)	GEP20053620B (de)
HR (1)	HRP20030833B1 (de)
HU (1)	HUP0401366A2 (de)
IL (1)	IL158359A0 (de)
IS (1)	IS2428B (de)
MA (1)	MA27026A1 (de)
MX (1)	MXPA03009392A (de)
MY (1)	MY128615A (de)
NO (1)	NO20035200D0 (de)
NZ (1)	NZ529173A (de)
OA (1)	OA12604A (de)
PA (1)	PA8545901A1 (de)
PE (1)	PE20030087A1 (de)
PL (1)	PL366384A1 (de)
PT (1)	PT1395242E (de)
RS (1)	RS87203A (de)
SI (1)	SI1395242T1 (de)
SK (1)	SK286227B6 (de)
SV (1)	SV2003001053A (de)
WO (1)	WO2002094220A1 (de)
ZA (1)	ZA200308393B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6001876A (en)	1996-07-24	1999-12-14	Warner-Lambert Company	Isobutylgaba and its derivatives for the treatment of pain
US8048917B2 (en)	2005-04-06	2011-11-01	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
JP2005539092A (ja) *	2002-08-15	2005-12-22	ファイザー・インク	縮合二環式または三環式アミノ酸の治療における使用
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
CN101862317A (zh) *	2002-12-13	2010-10-20	沃尼尔·朗伯有限责任公司	用于治疗纤维肌痛和其它疾病的普加巴林衍生物
DE60315258T2 (de) *	2002-12-20	2008-05-08	Dynogen Pharmaceuticals Inc., Waltham	Behandlung von nicht-schmerzhaften blasenstörungen mit modulatoren der alpha-2-delta-untereinheit des calciumkanals
US7169812B2 (en) *	2003-07-01	2007-01-30	Medtronic, Inc.	Process for producing injectable gabapentin compositions
DE602004024317D1 (de) *	2003-09-12	2010-01-07	Pfizer	Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
US7691880B2 (en) *	2003-10-08	2010-04-06	Mallinckrodt Inc.	Methylphenidate solution and associated methods of administration and production
US20050090548A1 (en) *	2003-10-23	2005-04-28	Medtronic, Inc.	Intrathecal gabapentin for treatment of epilepsy
US20050090549A1 (en) *	2003-10-23	2005-04-28	Medtronic, Inc.	Intrathecal gabapentin for treatment of pain
EP1543831A1 (de) *	2003-12-18	2005-06-22	Pfizer GmbH Arzneimittelwerk Gödecke	Zusammensetzung enthaltend Pregabalin
DE102004015752B4 (de) *	2004-03-31	2007-04-05	Christian-Albrechts-Universität Zu Kiel	Verwendung von Gabapentin-Laktam zur Behandlung renaler Erkrankungen
AU2005292853C1 (en) *	2004-10-14	2010-08-05	Daikin Industries, Ltd.	Atmosphere modifying method and spray agent and spray device used in the same
CA2618474A1 (en) *	2005-08-11	2007-02-15	Boehringer Ingelheim International Gmbh	Compounds for treating alzheimer's disease
JP2009504614A (ja) *	2005-08-11	2009-02-05	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	アルツハイマー病の治療用化合物
DE102007019071A1 (de) *	2007-04-23	2008-10-30	Ratiopharm Gmbh	Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
SG176464A1 (en)	2008-05-09	2011-12-29	Agency Science Tech & Res	Diagnosis and treatment of kawasaki disease
EP2246044A1 (de) *	2009-04-21	2010-11-03	Pierre Fabre Dermo-Cosmétique	Kinderärztliche Lösungen für Betablocker
HU230031B1 (hu)	2010-03-01	2015-05-28	Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság	Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
TR201005241A1 (tr) *	2010-05-25	2012-01-23	Sanovel �La� San. Ve T�C. A.�.	Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
WO2015144825A1 (en) *	2014-03-27	2015-10-01	Sanovel Ilac Sanayi Ve Ticaret A.S.	Oral liquid pharmaceutical solution of gabapentin
CN104940930A (zh) *	2015-05-31	2015-09-30	黑龙江佰彤儿童药物研究有限公司	一种治疗儿童癫痫药物口服乳剂及其制备方法
WO2018167628A1 (en)	2017-03-13	2018-09-20	Ftf Pharma Private Limited	Pharmaceutical composition of oral suspension of immunosuppressive agents
WO2019038584A1 (en)	2017-08-19	2019-02-28	Ftf Pharma Private Limited	An oral pharmaceutical composition comprising zonisamide and process of preparation thereof
WO2019186515A1 (en) *	2018-03-30	2019-10-03	Ftf Pharma Private Limited	Liquid pharmaceutical compositions of antiepileptic drugs
WO2020039264A2 (en) *	2018-08-18	2020-02-27	Ftf Pharma Private Limited	Chemotherapeutic pharmaceutical suspension for oral dosage
GB2591389A (en)	2018-08-18	2021-07-28	Ftf Pharma Private Ltd	Pharmaceuticals solution for oral dosage
EP3836898A2 (de)	2018-08-18	2021-06-23	FTF Pharma Private Limited	Pharmazeutische suspension zur oralen verabreichung
ES3064256T3 (en) *	2019-03-26	2026-04-23	Orion Corp	Pregabalin formulations and use thereof
MX2023008648A (es)	2021-01-22	2023-10-06	Egyt Gyogyszervegyeszeti Gyar	Formulacion topica que contiene compuestos fosfolipidicos modificados.
HU231397B1 (hu)	2021-01-22	2023-06-28	Egis Gyógyszergyár Zrt.	Pregabalint tartalmazó topikális gyógyszerkészítmény
US20240099989A1 (en) *	2021-02-05	2024-03-28	Kinki University	Agent for preventing or improving peripheral neuropathy
CA3230309A1 (en) *	2021-08-31	2023-03-09	Jr. Samuel A. Testino	Stable gabapentin powder
WO2024058812A1 (en)	2022-09-16	2024-03-21	Pyros Pharmaceuticals, Inc.	Vigabatrin liquid pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6294520B1 (en) *	1989-03-27	2001-09-25	Albert T. Naito	Material for passage through the blood-brain barrier
IL139298A0 (en) *	1998-05-15	2001-11-25	Warner Lambert Co	Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
IL155704A0 (en) *	2000-11-30	2003-11-23	Pfizer Prod Inc	Combination of gaba agonists and sorbitol dehydrogenase inhibitors

2002
- 2002-04-29 BR BR0209973-0A patent/BR0209973A/pt not_active IP Right Cessation
- 2002-04-29 AU AU2002258026A patent/AU2002258026B2/en not_active Ceased
- 2002-04-29 GE GE5340A patent/GEP20053620B/en unknown
- 2002-04-29 KR KR1020037015326A patent/KR100582963B1/ko not_active Expired - Fee Related
- 2002-04-29 NZ NZ529173A patent/NZ529173A/en unknown
- 2002-04-29 CA CA002446574A patent/CA2446574C/en not_active Expired - Fee Related
- 2002-04-29 ES ES02727834T patent/ES2265040T3/es not_active Expired - Lifetime
- 2002-04-29 DE DE60213592T patent/DE60213592T2/de not_active Expired - Fee Related
- 2002-04-29 JP JP2002590939A patent/JP2004534764A/ja active Pending
- 2002-04-29 CN CNB028098080A patent/CN100346779C/zh not_active Expired - Fee Related
- 2002-04-29 SI SI200230371T patent/SI1395242T1/xx unknown
- 2002-04-29 CZ CZ20033066A patent/CZ299755B6/cs not_active IP Right Cessation
- 2002-04-29 EP EP02727834A patent/EP1395242B1/de not_active Expired - Lifetime
- 2002-04-29 HR HR20030833A patent/HRP20030833B1/xx not_active IP Right Cessation
- 2002-04-29 AT AT02727834T patent/ATE334656T1/de not_active IP Right Cessation
- 2002-04-29 IL IL15835902A patent/IL158359A0/xx unknown
- 2002-04-29 AP APAP/P/2003/002907A patent/AP1815A/en active
- 2002-04-29 EE EEP200300587A patent/EE200300587A/xx unknown
- 2002-04-29 WO PCT/IB2002/001500 patent/WO2002094220A1/en not_active Ceased
- 2002-04-29 MX MXPA03009392A patent/MXPA03009392A/es active IP Right Grant
- 2002-04-29 PT PT02727834T patent/PT1395242E/pt unknown
- 2002-04-29 OA OA1200300296A patent/OA12604A/en unknown
- 2002-04-29 HU HU0401366A patent/HUP0401366A2/hu unknown
- 2002-04-29 EA EA200301152A patent/EA008087B1/ru not_active IP Right Cessation
- 2002-04-29 SK SK1411-2003A patent/SK286227B6/sk not_active IP Right Cessation
- 2002-04-29 DK DK02727834T patent/DK1395242T3/da active
- 2002-04-29 RS YU87203A patent/RS87203A/sr unknown
- 2002-04-29 PL PL02366384A patent/PL366384A1/xx not_active Application Discontinuation
- 2002-05-21 MY MYPI20021869A patent/MY128615A/en unknown
- 2002-05-22 EG EG20020541A patent/EG24078A/xx active
- 2002-05-23 DO DO2002000403A patent/DOP2002000403A/es unknown
- 2002-05-23 PE PE2002000433A patent/PE20030087A1/es not_active Application Discontinuation
- 2002-05-23 AR ARP020101922A patent/AR033922A1/es unknown
- 2002-05-24 PA PA20028545901A patent/PA8545901A1/es unknown
- 2002-05-24 SV SV2002001053A patent/SV2003001053A/es not_active Application Discontinuation
- 2002-05-28 US US10/156,213 patent/US20020198261A1/en not_active Abandoned
2003
- 2003-06-24 US US10/602,215 patent/US7256216B2/en not_active Expired - Lifetime
- 2003-10-09 IS IS6986A patent/IS2428B/is unknown
- 2003-10-28 ZA ZA2003/08393A patent/ZA200308393B/en unknown
- 2003-11-17 CR CR7150A patent/CR7150A/es not_active Application Discontinuation
- 2003-11-19 MA MA27406A patent/MA27026A1/fr unknown
- 2003-11-21 BG BG108376A patent/BG108376A/bg unknown
- 2003-11-24 NO NO20035200A patent/NO20035200D0/no not_active Application Discontinuation
2006
- 2006-08-10 CY CY20061101125T patent/CY1105147T1/el unknown

Also Published As

Publication number	Publication date
EA200301152A1 (ru)	2004-04-29
US20040072904A1 (en)	2004-04-15
IS2428B (is)	2008-10-15
HUP0401366A2 (hu)	2004-11-29
NO20035200L (no)	2003-11-24
SV2003001053A (es)	2003-03-18
JP2004534764A (ja)	2004-11-18
EP1395242B1 (de)	2006-08-02
RS87203A (sr)	2006-10-27
GEP20053620B (en)	2005-09-26
BG108376A (bg)	2005-04-30
CR7150A (es)	2004-02-23
CN1509165A (zh)	2004-06-30
DK1395242T3 (da)	2006-10-30
CY1105147T1 (el)	2010-03-03
IS6986A (is)	2003-10-09
AP2003002907A0 (en)	2003-12-31
MA27026A1 (fr)	2004-12-20
BR0209973A (pt)	2004-04-06
OA12604A (en)	2006-06-08
MXPA03009392A (es)	2004-01-29
PT1395242E (pt)	2006-11-30
ATE334656T1 (de)	2006-08-15
US7256216B2 (en)	2007-08-14
KR100582963B1 (ko)	2006-05-24
US20020198261A1 (en)	2002-12-26
CA2446574A1 (en)	2002-11-28
NO20035200D0 (no)	2003-11-24
HRP20030833A2 (en)	2004-08-31
CZ299755B6 (cs)	2008-11-12
ES2265040T3 (es)	2007-02-01
EP1395242A1 (de)	2004-03-10
KR20040003006A (ko)	2004-01-07
HK1062646A1 (zh)	2004-11-19
DE60213592D1 (de)	2006-09-14
EA008087B1 (ru)	2007-02-27
EG24078A (en)	2008-05-11
NZ529173A (en)	2005-07-29
CZ20033066A3 (cs)	2004-08-18
PE20030087A1 (es)	2003-02-14
HRP20030833B1 (en)	2007-04-30
PL366384A1 (en)	2005-01-24
WO2002094220A1 (en)	2002-11-28
DE60213592T2 (de)	2007-08-09
AU2002258026B2 (en)	2007-08-02
MY128615A (en)	2007-02-28
AR033922A1 (es)	2004-01-07
SK286227B6 (sk)	2008-05-06
ZA200308393B (en)	2005-04-26
CA2446574C (en)	2008-04-01
DOP2002000403A (es)	2002-11-30
SK14112003A3 (sk)	2004-08-03
SI1395242T1 (en)	2006-10-31
IL158359A0 (en)	2004-05-12
AP1815A (en)	2008-01-04
PA8545901A1 (es)	2003-09-05
CN100346779C (zh)	2007-11-07

Publication	Publication Date	Title
EE200300236A (et)	2003-08-15	1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod
EE200300581A (et)	2004-02-16	Karboksamiid-asendatud fenüüluurea derivaadid ja nende kasutamine, ravim ja selle valmistamismeetod
EE04464B1 (et)	2005-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200300327A (et)	2003-10-15	Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
EE200300369A (et)	2003-10-15	Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
DK1395242T3 (da)	2006-10-30	Flydende farmaceutisk sammensætning
EE200200487A (et)	2004-02-16	Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE05214B1 (et)	2009-10-15	Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
EE200300171A (et)	2003-06-16	Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
EE05475B1 (et)	2011-10-17	Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon
EE200300370A (et)	2003-10-15	Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200400028A (et)	2004-04-15	Ravimpreparaat, selle valmistamise meetod ja selle kasutamine meditsiinis
NO20031273L (no)	2003-05-14	Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
EE200000596A (et)	2002-06-17	Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
IS6378A (is)	2002-05-10	Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
PL394600A1 (pl)	2011-07-18	Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
EE05175B1 (et)	2009-06-15	Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis
EE200300488A (et)	2003-12-15	Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon
EE200300255A (et)	2003-08-15	Asitromütsiin monohüdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises
NO326689B1 (no)	2009-01-26	Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
EE04346B1 (et)	2004-08-16	Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE05168B1 (et)	2009-06-15	N-guanidinoalklamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
EE04902B1 (et)	2007-10-15	Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
EE04855B1 (et)	2007-06-15	Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine
HUP0401369A3 (en)	2006-05-29	Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof